Bio-Rad Laboratories, Inc. (BIO)
366.01
-4.47
(-1.21%)
USD |
NYSE |
Nov 13, 16:00
366.01
0.00 (0.00%)
After-Hours: 19:59
Bio-Rad Laboratories Enterprise Value : 9.660B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 9.660B |
| November 11, 2026 | 10.08B |
| November 10, 2026 | 10.09B |
| November 09, 2026 | 10.14B |
| November 06, 2026 | 9.958B |
| November 05, 2026 | 9.620B |
| November 04, 2026 | 9.916B |
| November 03, 2026 | 9.779B |
| November 02, 2026 | 9.544B |
| October 30, 2026 | 9.706B |
| October 29, 2026 | 10.03B |
| October 28, 2026 | 10.05B |
| October 27, 2026 | 9.943B |
| October 26, 2026 | 9.712B |
| October 23, 2026 | 9.646B |
| October 22, 2026 | 9.472B |
| October 21, 2026 | 9.392B |
| October 20, 2026 | 9.230B |
| October 19, 2026 | 9.185B |
| October 16, 2026 | 9.209B |
| October 15, 2026 | 9.508B |
| October 14, 2026 | 9.444B |
| October 13, 2026 | 9.479B |
| October 12, 2026 | 9.497B |
| October 09, 2026 | 9.544B |
| Date | Value |
|---|---|
| October 08, 2026 | 9.389B |
| October 07, 2026 | 9.591B |
| October 06, 2026 | 9.616B |
| October 05, 2026 | 9.911B |
| October 02, 2026 | 9.624B |
| October 01, 2026 | 9.259B |
| September 30, 2026 | 9.854B |
| September 29, 2026 | 9.899B |
| September 28, 2026 | 9.849B |
| September 25, 2026 | 9.937B |
| September 24, 2026 | 10.11B |
| September 23, 2026 | 9.881B |
| September 22, 2026 | 9.899B |
| September 21, 2026 | 9.839B |
| September 18, 2026 | 9.815B |
| September 17, 2026 | 9.975B |
| September 16, 2026 | 9.885B |
| September 15, 2026 | 9.857B |
| September 14, 2026 | 9.605B |
| September 11, 2026 | 9.625B |
| September 10, 2026 | 9.610B |
| September 09, 2026 | 9.830B |
| September 08, 2026 | 9.914B |
| September 04, 2026 | 10.07B |
| September 03, 2026 | 10.12B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 294.59B |
| Danaher Corp. | 185.41B |
| Agilent Technologies, Inc. | 50.97B |
| Illumina, Inc. | 32.83B |
| Bruker Corp. | 10.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 458.60M |
| Revenue (Quarterly) | 656.40M |
| Total Expenses (Quarterly) | 197.80M |
| EPS Diluted (Quarterly) | 17.02 |
| Gross Profit Margin (Quarterly) | 53.82% |
| Profit Margin (Quarterly) | 69.87% |
| Earnings Yield | 10.37% |
| Operating Earnings Yield | 2.49% |
| Normalized Earnings Yield | 3.063 |